Overcoming ADC Resistance: Construction and Preclinical Applications of Enhertu-Resistant Models

April 15, 2026



Webinar Outline:

• Construction and validation of an Enhertu-induced resistant CDX model

• Investigation of underlying resistance mechanisms

• Characterization of a primary Enhertu-resistant PDX model


For more information, please contact sales@gempharmatech.com

Contact Us